Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 8,701-8,712 of 10,592
Device study icon
CompletedNCT03075202

Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 21 Years to 65 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT04878627

Role of CBD in Regulating Meal Time Anxiety in Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Eating disorders, AnxietyDrugA study involving a medication or substance.From 18 Years to 40 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Eating disorders, Anxiety
Drug study icon
CompletedNCT00000284

Role of Metabolites in Addiction (1) - 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 45 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Addiction
Drug study icon
CompletedNCT00000288

Role of Metabolites in Addiction (2) - 5

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 45 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Addiction
Drug study icon
CompletedNCT00000289

Role of Metabolites in Addiction (3) - 6

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 45 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Addiction
Drug study icon
CompletedNCT00000296

Role of Metabolites in Addiction (4) - 13

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 45 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Addiction
Behavioral study icon
TerminatedNCT05910775

Role Of Non-Specific Effects in The Treatment of Depression With Esketamine

This study exists to understand how ketamine treatment holds up over time after the earliest research stage. Researchers are trying to understand what ketamine treatment could change in day-to-day care and decision-making.

In United States
DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Yale University
Condition
Depression
Drug study icon
TerminatedNCT01631630

Role of Proinflammatory Signaling in Alcohol Craving

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Addiction
Behavioral study icon
CompletedNCT04150718

Role of Slow-wave Activity and Plasticity in MDD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
DepressionBehavioralFrom 25 Years to 50 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Depression
Drug study icon
CompletedNCT00102102

Role of Substance P in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrug
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
PTSD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.